Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Ned Tijdschr Geneeskd ; 150(42): 2312, 2006 Oct 21.
Artículo en Holandés | MEDLINE | ID: mdl-17089548

RESUMEN

A 40-year-old woman presented with a diastolic cardiac murmur. Transthoracic echocardiography revealed a quadricuspid aortic valve with moderate regurgitation.


Asunto(s)
Insuficiencia de la Válvula Aórtica/etiología , Soplos Cardíacos/diagnóstico , Adulto , Insuficiencia de la Válvula Aórtica/diagnóstico , Insuficiencia de la Válvula Aórtica/diagnóstico por imagen , Femenino , Soplos Cardíacos/diagnóstico por imagen , Humanos , Ultrasonografía
2.
Neth Heart J ; 11(2): 84-88, 2003 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25696185

RESUMEN

We report three patients in whom dobutamine stress magnetic imaging (DS-MRI) was essential in assessing myocardial ischaemia. Two patients were referred to the cardiologist because of chest pain. Patient A had typical exertional angina and a normal resting electrocardiogram (ECG). Patient B had typical exercise-induced angina and had recently experienced an attack of severe chest pain at rest for 15 minutes. The ECG showed a complete left bundle branch block (LBBB). Patient C was referred for heart failure of unknown origin. There were no symptoms of chest pain during rest or exercise. Echocardiography in this patient demonstrated global left ventricular (LV) dilatation, systolic dysfunction and a small dyskinetic segment in the inferior wall. In all these patients exercise stress testing had failed to demonstrate myocardial ischaemia. Patients A and C produced normal findings whereas in patient B the abnormal repolarisation due to pre-existent LBBB precluded a diagnosis of ischaemia. Breath-hold DS-MRI was performed to study LV wall motion and wall thickening at rest through increasing doses of dobutamine. A test was considered positive for myocardial ischaemia if wall motion abnormalities developed at high-dose levels of the drug (20 µg/kg/min or more with a maximum of 40 µg/kg/min) in previously normal vascular territories or worsened in a segment that was normal at baseline. Recovery of wall thickening in a previously hypokinetic or akinetic segment at a low dose of dobutamine (5-10 µg/kg/min) was taken as proof of viability. Patients A and B developed hypokinesia progressing into akinesia at high-dose dobutamine in the anteroseptal area of the LV indicative of ischaemia. These findings were corroborated by coronary angiography demonstrating severe coronary artery disease which led to coronary artery bypass grafting (CABG) in patient A and balloon angioplasty in patient B. In patient C global recovery of LV contractions during low-dose dobutamine was followed by hypokinesia in the inferoseptal area during high-dose dobutamine. This biphasic response indicates myocardial viability as well as ischaemia. CABG was carried out because of multiple stenoses in the left coronary artery. Post-operatively LV function normalised. DS-MRI is a valuable method for detecting myocardial ischaemia and viability in patients with suspected coronary artery, and can be applied in every hospital with MRI equipment at its disposal.

3.
Cephalalgia ; 19(10): 880-5, 1999 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-10668107

RESUMEN

Because the "intensity dependence" of cortical auditory evoked potentials (IDAP) is under serotonergic control, it can be used to assess central antimigraine effects of 5HT1B/1D agonists. We measured IDAP before and 2 h after naratriptan (5 mg, n = 19) and zolmitriptan (5 mg, n = 19) in healthy volunteers. IDAP was expressed as the amplitude-stimulus intensity function ("ASF slope"). Naratriptan tended to increase ASF slope (mean difference 0.23 +/- 0.62 microV/10 dB, p = 0.06) while zolmitriptan (0.08 +/- 0.95 microV/10 dB, p = 0.35) did not. We assessed the suitability of IDAP for measuring central antimigraine drug effects using repeatability data (see companion paper). We calculated the trade-off between the size of the expected drug effects (ASF slope difference) and the necessary sample size. Because of poor repeatability 36 to 80 subjects are required to detect ASF slope changes in the 0.25-0.5 microV/10 dB range. These data can be used to design trials using IDAP.


Asunto(s)
Corteza Cerebral/efectos de los fármacos , Potenciales Evocados Auditivos/efectos de los fármacos , Indoles/farmacología , Oxazoles/farmacología , Oxazolidinonas , Piperidinas/farmacología , Agonistas de Receptores de Serotonina/farmacología , Adolescente , Adulto , Corteza Cerebral/fisiología , Femenino , Humanos , Masculino , Reproducibilidad de los Resultados , Tamaño de la Muestra , Triptaminas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA